Huankai Yao

Huankai Yao

Auto-generated profile, based on publicly available information

Huankai Yao

Xuzhou Medical University

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2017 in Phytochemistry Reviews
Verified
Journal Article
Closed access
PDF file
HCHui Cao
Hui Cao
Tsun-Thai ChaiTsun-Thai Chai
Tsun-Thai Chai
XWXin Wang
Xin Wang
MMMaria Flaviana Bezerra Morais-Braga
Maria Flaviana Bezerra Morais-Braga
JYJing-Hua Yang
Jing-Hua Yang
HCHenrique Coutinho
Henrique Coutinho

1 September 2015 in Drug Discovery Today
Verified
Journal Article
Closed access
ZZZhonglin Zang
Zhonglin Zang
XHXiaohui Hu
Xiaohui Hu
WZWen Zhang
Wen Zhang
HYHuankai Yao
Huankai Yao
KTKin Yip Tam
Kin Yip Tam

21 June 2019 in Journal of Natural Medicines
Verified
Journal Article
Closed access
PDF file
YLYan Li
Yan Li
JSJing Shi
Jing Shi
XSXinting Sun
Xinting Sun
YLYafeng Li
Yafeng Li
YDYinyin Duan
Yinyin Duan
HYHuankai Yao
Huankai Yao

30 November 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YLYing Li
Ying Li
MSMingzhu Shan
Mingzhu Shan
YZYao Zhu
Yao Zhu
HYHuankai Yao
Huankai Yao
HLHongchun Li
Hongchun Li
ZZZuobin Zhu
Zuobin Zhu
Candidiasis causes high morbidity and mortality among immunocompromised patients. Antifungal drug resistance and cytotoxicity highlight the need of effective antifungal therapeutics. In this study, we found that kalopanaxsaponin A (KPA), a triterpenoid saponin natural product, could inhibit the proliferation of various Candida species, and exerted a fungicidal effect against C. albicans. To further explore its antifungal action mode, spectrofluorophotometer, fluorescence microscopy and transmission electron microscopy were performed, showing that KPA treatment induced the accumulation of intracellular reactive oxygen species (ROS), resulting in mitochondrial dysfunction. Meanwhile, KPA treatment also broke down the membrane barrier of C. albicans causing the leakage of intracellular trehalose, the entrance of extracellular impermeable substance and the decrease of ergosterol content. Both ROS accumulation and membrane destruction contributed to the death of C. albicans cells. Our work preliminarily elucidated the potential mechanisms of KPA against C. albicans on a cellular level, and might provide a potential option for the treatment of clinical candidiasis.

11 December 2021 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
HYHuankai Yao
Huankai Yao
WZWenting Zhang
Wenting Zhang
FYFeng Yang
Feng Yang
FAFengwei Ai
Fengwei Ai
DDDan Du
Dan Du
YLYan Li
Yan Li
Diabetic nephropathy (DN) is one of the severe microvascular complications of diabetes mellitus. Oxidative stress resulting from aberrant metabolism of glucose mediates renal inflammation and fibrosis in the progression of DN. Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor regulating the expression of antioxidant enzymes. Activating Nrf2 will give a promising therapy for DN. To discover novel Nrf2 activators, we have investigated caffeoylisocitric acid using mesangial cells under high glucose. The results showed at 10 μM, caffeoylisocitric acid significantly inhibited the self-limited proliferation of mesangial cells induced by high glucose. Further assessments have disclosed caffeoylisocitric acid mitigated oxidative stress, inflammation and accumulation of extracellular matrix resulting from high glucose via inactivating MAPK signalling. Meanwhile activation of Nrf2 was observed and involved in these effects through the interaction between Keap1 and caffeoylisocitric acid to disrupt Keap1-Nrf2 complex. Therefore, caffeoylisocitric acid is a promising Nrf2 activator targeting DN.

28 May 2018 in Natural Product Research
Verified
Journal Article
Closed access
HYHuankai Yao
Huankai Yao
WZWenting Zhang
Wenting Zhang
HWHuiling Wu
Huiling Wu
MYMing Yang
Ming Yang
PWPengxiang Wei
Pengxiang Wei
YLYan Li
Yan Li
Ischemic cerebral stroke is a severe cause of human death and disability. Natural products play an important role in the discovery of novel therapy for cerebral ischemia. Herein, we investigate the neuroprotective effects of sikokianin A identifiedfrom Wikstroemia indica using PC12 cell exposed to OGD/R. The results revealed sikokianin A can improve the poor viability and release of intracellular LDH in PC12 cells induced by OGD/R. Further studies have demonstrated the increased ROS and MDA together with reduced SOD activity were attenuated by sikokianin A. Meanwhile, decreased mitochondrial membrane potential, activated Caspase-3, down-regulated Bcl-2 and up-regulated Bax were reversed. These results indicate the protective effects of sikokianin A are associated with inhibiting oxidative stress and apoptosis resulting from OGD/R. Additionally, sikokianin A can activate Nrf2 and downstream HO-1 in PC12 cells treated by OGD/R, which implied Nrf2/HO-1 signaling pathway was involved in the protective effects of sikokianin A.